150 related articles for article (PubMed ID: 22268592)
1. An alternative respiratory pathway on Candida krusei: implications on susceptibility profile and oxidative stress.
Costa-de-Oliveira S; Sampaio-Marques B; Barbosa M; Ricardo E; Pina-Vaz C; Ludovico P; Rodrigues AG
FEMS Yeast Res; 2012 Jun; 12(4):423-9. PubMed ID: 22268592
[TBL] [Abstract][Full Text] [Related]
2. The alternative oxidase of Candida albicans causes reduced fluconazole susceptibility.
Yan L; Li M; Cao Y; Gao P; Cao Y; Wang Y; Jiang Y
J Antimicrob Chemother; 2009 Oct; 64(4):764-73. PubMed ID: 19656781
[TBL] [Abstract][Full Text] [Related]
3. Evidence of an alternative oxidase pathway for mitochondrial respiration in the scuticociliate Philasterides dicentrarchi.
Mallo N; Lamas J; Leiro JM
Protist; 2013 Nov; 164(6):824-36. PubMed ID: 24211656
[TBL] [Abstract][Full Text] [Related]
4. Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
Quindós G; Sánchez-Vargas LO; Villar-Vidal M; Eraso E; Alkorta M; Hernández-Almaraz JL
Int J Antimicrob Agents; 2008 Mar; 31(3):266-71. PubMed ID: 18054468
[TBL] [Abstract][Full Text] [Related]
5. [CHROMAgar Candida with fluconazole: comparison with microdilution techniques].
Linares MJ; Charriel G; Solís F; Casal M
Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):493-7. PubMed ID: 14572382
[TBL] [Abstract][Full Text] [Related]
6. Rapid identification of fluconazole resistance using Chromagar Candida.
Verghese SL; Padmaja P; Sutha P; Mathew T; John ES
Indian J Pathol Microbiol; 2000 Jul; 43(3):343-6. PubMed ID: 11218683
[TBL] [Abstract][Full Text] [Related]
7. Rapid identification of fluconazole resistance using Chrom agar Candida.
Verghese SL; Padmaja P; Sutha P; Mathew T; Johni ES
Indian J Pathol Microbiol; 2001 Jul; 44(3):305-7. PubMed ID: 12024918
[TBL] [Abstract][Full Text] [Related]
8. [Candida krusei (Castellani) Berkhout--a potential pathogen with growing importance].
Otcenásek M; Buchta V
Epidemiol Mikrobiol Imunol; 1998 Dec; 47(4):137-40. PubMed ID: 9919813
[TBL] [Abstract][Full Text] [Related]
9. Impact of mitochondrial alternative oxidase expression on the response of Nicotiana tabacum to cold temperature.
Wang J; Rajakulendran N; Amirsadeghi S; Vanlerberghe GC
Physiol Plant; 2011 Aug; 142(4):339-51. PubMed ID: 21401618
[TBL] [Abstract][Full Text] [Related]
10. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
[TBL] [Abstract][Full Text] [Related]
11. Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years.
Chen YC; Chang SC; Luh KT; Hsieh WC
J Antimicrob Chemother; 2003 Jul; 52(1):71-7. PubMed ID: 12775680
[TBL] [Abstract][Full Text] [Related]
12. Cloning and functional expression of the mitochondrial alternative oxidase of Aspergillus fumigatus and its induction by oxidative stress.
Magnani T; Soriani FM; Martins VP; Nascimento AM; Tudella VG; Curti C; Uyemura SA
FEMS Microbiol Lett; 2007 Jun; 271(2):230-8. PubMed ID: 17425662
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis reveals effects of tobacco alternative oxidase gene (NtAOX1a) on regulation of defence responses against abiotic and biotic stresses.
Zhang Y; Xi D; Wang J; Zhu D; Guo X
Biosci Rep; 2009 Jul; 29(6):375-83. PubMed ID: 19125696
[TBL] [Abstract][Full Text] [Related]
14. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.
Xu Y; Chen L; Li C
J Antimicrob Chemother; 2008 Apr; 61(4):798-804. PubMed ID: 18218640
[TBL] [Abstract][Full Text] [Related]
16. Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?
Oxman DA; Chow JK; Frendl G; Hadley S; Hershkovitz S; Ireland P; McDermott LA; Tsai K; Marty FM; Kontoyiannis DP; Golan Y
J Antimicrob Chemother; 2010 Jul; 65(7):1460-5. PubMed ID: 20430790
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of voriconazole against Candida species isolated in Taiwan.
Yang YL; Cheng HH; Lo HJ
Int J Antimicrob Agents; 2004 Sep; 24(3):294-6. PubMed ID: 15325436
[TBL] [Abstract][Full Text] [Related]
18. In vitro fluconazole susceptibility of 1565 clinical isolates of Candida species evaluated by the disk diffusion method performed using NCCLS M44-A guidelines.
Testore GP; Dori L; Buonomini AR; Schito GC; Soro O; Fortina G; Andreoni S; Carlone N; Tullio V; Andreoni M
Diagn Microbiol Infect Dis; 2004 Nov; 50(3):187-92. PubMed ID: 15541604
[TBL] [Abstract][Full Text] [Related]
19. [Species distribution and fluconazole susceptibility of yeasts of genus Candida isolated from hospitalized and ambulatory patients].
Alburquerque C; Hermosilla G; Tapia C
Rev Chilena Infectol; 2009 Oct; 26(5):435-9. PubMed ID: 19915753
[TBL] [Abstract][Full Text] [Related]
20. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Meis JF; Gould IM; Fu W; Colombo AL; Rodriguez-Noriega E;
J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
